Cargando…

The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma

INTRODUCTION: Soluble MHC class I-related chain A (sMICA) and B (sMICB) play a critical role tumor evolution and poor prognosis through an immune evasion mechanism. Thus, this study determines the interaction between sMICA/sMICB and the tumor immune environment in newly diagnosed diffuse large B-cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Sang Eun, Park, Sujin, Cho, Junhun, Ryu, Kyung Ju, Yandava, Booma, Lee, Sewon, Kim, Seok Jin, Kim, Won Seog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687412/ https://www.ncbi.nlm.nih.gov/pubmed/38033491 http://dx.doi.org/10.3389/fonc.2023.1194315

Ejemplares similares

Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus
por: Hervier, Baptiste, et al.
Publicado: (2021)

sMICA as novel and early predictors for acute myocardial infarction
por: Fu, Cunyu, et al.
Publicado: (2016)

Association of MICA and MICB polymorphisms with the susceptibility of leukemia in Korean patients
por: Baek, In-Cheol, et al.
Publicado: (2018)

Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer
por: Chen, Jiong, et al.
Publicado: (2015)

Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB
por: Tang, Kai-Fu, et al.
Publicado: (2008)

In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer
por: Schrambach, Stéphanie, et al.
Publicado: (2007)

sMICA and its emerging role as a prognostic and diagnostic indicator in systemic malignancies besides hepatocellular carcinoma
por: Kapoor, Shailendra
Publicado: (2013)

Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells
por: Weiss-Steider, Benny, et al.
Publicado: (2011)

The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance
por: Hauer, Vanessa, et al.
Publicado: (2019)

Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids
por: Klöss, Stephan, et al.
Publicado: (2015)

Association of MICA-TM and MICB C1_2_A Microsatellite Polymorphisms with Tumor Progression in Patients with Colorectal Cancer
por: Kopp, R., et al.
Publicado: (2009)

Single-Nucleotide Polymorphisms in MICA and MICB Genes Could Play a Role in the Outcome in AML Patients after HSCT
por: Machuldova, Alena, et al.
Publicado: (2021)

The Human Herpesvirus-7 (HHV-7) U21 Immunoevasin Subverts NK-Mediated Cytoxicity through Modulation of MICA and MICB
por: Schneider, Christine L., et al.
Publicado: (2011)

MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue
por: Ghadially, Hormas, et al.
Publicado: (2017)

A comparative study of smica in various body fluids of diagnosed cervical cancer patients and healthy women
por: Pachani, Pooja A., et al.
Publicado: (2022)

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
por: Lucijanic, Marko, et al.
Publicado: (2021)

Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy
por: Qian, Liren, et al.
Publicado: (2016)

Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway
por: Shi, Pengfei, et al.
Publicado: (2014)

MICB Allele Genotyping on Microarrays by Improving the Specificity of Extension Primers
por: Baek, In-Cheol, et al.
Publicado: (2015)

Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
por: Raneros, Aroa Baragaño, et al.
Publicado: (2017)

Impact of transformation on the survival of patients diagnosed with follicular lymphoma that progressed within 24 months
por: Yoon, Sang Eun, et al.
Publicado: (2021)

Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
por: Raneros, Aroa Baragaño, et al.
Publicado: (2018)

An integrated prognostic model for diffuse large B‐cell lymphoma treated with immunochemotherapy
por: Rodríguez, Marta, et al.
Publicado: (2022)

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance
por: Kim, Hee Kyung, et al.
Publicado: (2020)

Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ
por: Koh, Hyun‐Hee, et al.
Publicado: (2023)

Cold welding of gold nanoparticles on mica substrate: Self-adjustment and enhanced diffusion
por: Cha, Song-Hyun, et al.
Publicado: (2016)

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
por: Yhim, Ho-Young, et al.
Publicado: (2020)

A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

MICB0106 gene polymorphism is associated with ulcerative colitis in central China
por: Li, Yi, et al.
Publicado: (2009)

Genetic Variants of MICB and PLCE1 and Associations with Non-Severe Dengue
por: Whitehorn, James, et al.
Publicado: (2013)

Genetic variants of MICB and PLCE1 and associations with the laboratory features of dengue
por: Whitehorn, James, et al.
Publicado: (2017)

High MICB expression as a biomarker for good prognosis of colorectal cancer
por: Feng, Qingyang, et al.
Publicado: (2020)

Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy
por: Hong, Junshik, et al.
Publicado: (2014)

A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B‐cell lymphoma
por: Lee, Hyunjee, et al.
Publicado: (2023)

CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain
por: Cho, Junhun, et al.
Publicado: (2022)

Circulating Levels of Soluble MICB in Infants with Symptomatic Primary Dengue Virus Infections
por: Libraty, Daniel H., et al.
Publicado: (2014)

Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Establishment of HLA class I and MICA/B null HEK-293T panel expressing single MICA alleles to detect anti-MICA antibodies
por: Jeon, Ji-Ho, et al.
Publicado: (2021)

Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma
por: Lamure, Sylvain, et al.
Publicado: (2019)

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
por: Lee, Boram, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mavvhfugo0r33no42gbvrvqdp9